Drugs

Public Meetings: Enhanced Drug Distribution Security under the Drug Supply Chain Security Act

The FDA is announcing three public meetings entitled “Enhanced Drug Distribution Security under the Drug Supply Chain Security Act (DSCSA).” These public meetings are intended to provide members of the drug distribution supply chain and other interested stakeholders an opportunity to discuss strategies and issues related to the enhanced drug distribution security provisions of the DSCSA.

Dates 

  • August 23, 2017
  • December 5-6, 2017
  • February 28, 2018

Time

9 am to 4 pm

Location

FDA White Oak Campus
Building 31, Conference Center, Great Room (Room 1503), Section A
10903 New Hampshire Ave.
Silver Spring, MD 20993-0002

Federal Register Notice

Enhanced Drug Distribution Security under the Drug Supply Chain Security Act; Public Meetings; Request for Comments: Docket No. FDA-2017-N-3857.

Registration

See registration page to request registration for the public meetings. There is no registration fee for the public meetings and no on-site registration.

Dates

Topics

Advance Registration

August 23, 2017

  • Supply chain security in 2023
  • Enhanced drug distribution security needs
Deadline: July 31, 2017
We have reached the maximum capacity. Registration is closed.

December 5-6, 2017

  • Electronic interoperability
  • Standards for data exchange
  • Data architecture
  • Aggregation and inference

October 2-27, 2017

February 28, 2018

  • Further refinement of enhanced drug distribution security needs
  • Building capacity for a unit-level system

January 2-26, 2018

FDA Campus Information

Entrance for the public meeting participants is through Building 1, where routine security check procedures are performed. See public meeting attendee information for details.

If you need special accommodations due to a disability, please contact Daniel Bellingham at least seven days in advance of the public workshop at 301-796-3130 or CDERODSIRpublicmeetings@fda.hhs.gov.

Agenda and Meeting Materials

The agenda and relevant meeting materials will be available prior to each meeting. Please check this webpage for updated information after each meeting.

Information for the August 23 meeting:

Webcast Information

Portions of each public meeting will be recorded and webcast on the day of the meeting in listen-only mode. This webcast information will be available prior to future meetings.

The August 23 meeting recordings are available at the following links:

Submit Comments

Submit electronic comments regarding the topics of the meeting to http://www.regulations.gov, or submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852. All submissions should include the Docket No. FDA-2017-N-3857. See the Federal Register Notice for the specific deadline for submission for each meeting.

Back to Top

Page Last Updated: 09/15/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English